Yield10 Bioscience Inc (YTEN) News

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Yield10 Bioscience Announces Second Quarter 2024 Financial Results

WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or...

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

- Nufarm to pay up to USD $5 million in consideration for the license-The parties will negotiate the sale of...

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina

WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc...

Form 8-K - Current report

Form 8-K - Current report

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label

- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report